Literature DB >> 491973

Sterol balance in abetalipoproteinemia: studies in a patient with homozygous familial hypobetalipoproteinemia.

D R Illingworth, W E Connor, N R Buist, B M Jhaveri, D S Lin, M P McMurry.   

Abstract

A new case of homozygous familial hypobetalipoproteinemia is reported in a 16-yr-old girl. Apoprotein B was absent from plasma and the patient had acanthocytes and steatorrhea, but minimal neurologic dysfunction. Total body cholesterol synthesis was assessed intermittently over a 30-mo period by sterol balance techniques. The rate of synthesis of cholesterol was higher (15.0 +/- 2.9 mg/kg/day) in the patient (8.3 +/- 0.4 mg/kg/day than in 3 control children, p less than 0.005). Bile acid synthesis was similar (4.6 +/- 1.8 versus 4.0 +/- 1.7 mg/kg/day) in the patient and controls, but total body sterol synthesis was significantly higher (19.6 +/- 3.0 versus 12.2 +/- 2.0, p less than 0.005). The absorption of orally administered [1,2,(3)H] cholesterol in the patient was low and less than 0.5% of the label appeared in the total plasma volume at all times up to 48 hr. Estimates of the extent that malabsorption of biliary cholesterol contributes to the enhanced excretion of neutral sterols in this case indicate that all of the increase can be explained on this basis. Thus, although the mechanisms for the increased sterol synthesis in this case may relate to the absence of chylomicrons and low density lipoproteins in plasma, the magnitude of the increase can be fully explained on the basis of a compensatory mechanism to maintain cholesterol homeostasis in the face of enhanced fecal losses.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 491973     DOI: 10.1016/0026-0495(79)90155-0

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Homozygous hypobetalipoproteinaemia and phenylketonuria.

Authors:  J U Leititis; M Stahl; W Tackmann; H Wick; A Wildberg
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

2.  Hormone changes during the menstrual cycle in abetalipoproteinemia: reduced luteal phase progesterone in a patient with homozygous hypobetalipoproteinemia.

Authors:  D R Illingworth; D K Corbin; E D Kemp; E J Keenan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

3.  Role of apolipoprotein E-containing lipoproteins in abetalipoproteinemia.

Authors:  C B Blum; R J Deckelbaum; L D Witte; A R Tall; J Cornicelli
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

4.  Apolipoprotein B detected in the plasma of a patient with homozygous hypobetalipoproteinaemia: implications for aetiology.

Authors:  G M Berger; G Brown; H E Henderson; F Bonnici
Journal:  J Med Genet       Date:  1983-06       Impact factor: 6.318

5.  Inability of serum from abetalipoproteinemic subjects to stimulate proliferation of human smooth muscle cells and dermal fibroblasts in vitro.

Authors:  D L Layman; B J Jelen; D R Illingworth
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

6.  Regulation of low density lipoprotein receptors by plasma lipoproteins from patients with abetalipoproteinemia.

Authors:  D R Illingworth; N A Alam; E E Sundberg; F C Hagemenas; D L Layman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.